The global insulin pump market size was accounted for USD 6.58 billion in 2024, grew to USD 7.12 billion in 2025 and is predicted to surpass around USD 14.54 billion by 2034, representing a healthy CAGR of 8.25% between 2025 and 2034. The North America insulin pump market size was calculated at USD 3.03 billion in 2024 and is expected to grow at a fastest CAGR of 8.36% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Insulin Pump Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Insulin Pump Market, by Pump Type, 2025-2034
8.1.1. Tethered Pump
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Patch Pump
8.1.2.1. Market Revenue and Forecast (2022-2034)
9.1. Insulin Pump Market, by Application, 2025-2034
9.1.1. Battery
9.1.1.1. Market Revenue and Forecast (2022-2034)
9.1.2. Insulin Set Insertion Devices
9.1.2.1. Market Revenue and Forecast (2022-2034)
9.1.3. Insulin Reservoir
9.1.3.1. Market Revenue and Forecast (2022-2034)
10.1. Insulin Pump Market, by Disease Indication Type, 2025-2034
10.1.1. Type 1 Diabetes
10.1.1.1. Market Revenue and Forecast (2022-2034)
10.1.2. Type 2 Diabetes
10.1.2.1. Market Revenue and Forecast (2022-2034)
11.1. Insulin Pump Market, by End User Type, 2025-2034
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2022-2034)
11.1.2. Clinics
11.1.2.1. Market Revenue and Forecast (2022-2034)
11.1.3. Homecare
11.1.3.1. Market Revenue and Forecast (2022-2034)
11.1.4. Laboratories
11.1.4.1. Market Revenue and Forecast (2022-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Pump (2022-2034)
12.1.2. Market Revenue and Forecast, by Application (2022-2034)
12.1.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.1.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.1.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.1.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Pump (2022-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2022-2034)
12.1.6.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.1.6.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Pump (2022-2034)
12.2.2. Market Revenue and Forecast, by Application (2022-2034)
12.2.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.2.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.2.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.2.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Pump (2022-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
12.2.6.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.2.6.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Pump (2022-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2022-2034)
12.2.7.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.2.7.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Pump (2022-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2022-2034)
12.2.8.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.2.8.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Pump (2022-2034)
12.3.2. Market Revenue and Forecast, by Application (2022-2034)
12.3.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.3.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.3.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.3.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Pump (2022-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
12.3.6.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.3.6.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Pump (2022-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2022-2034)
12.3.7.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.3.7.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Pump (2022-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2022-2034)
12.3.8.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.3.8.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Pump (2022-2034)
12.4.2. Market Revenue and Forecast, by Application (2022-2034)
12.4.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.4.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.4.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.4.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Pump (2022-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
12.4.6.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.4.6.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Pump (2022-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2022-2034)
12.4.7.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.4.7.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Pump (2022-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2022-2034)
12.4.8.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.4.8.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Pump (2022-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2022-2034)
12.5.5.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.5.5.4. Market Revenue and Forecast, by End User Type (2022-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Pump (2022-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2022-2034)
12.5.6.3. Market Revenue and Forecast, by Disease Indication Type (2022-2034)
12.5.6.4. Market Revenue and Forecast, by End User Type (2022-2034)
13.1. Medtronic Plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Insulet Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Medzer
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Microport Scientific
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Eoflow
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Debiotech S.A.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Lenomed Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Microtech Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cequr SA
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. F. Hoffmann La Roche AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Ypsomed AG
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample